The main effect of pharmaco-therapeutic effects of drugs: works by inhibition of DNA synthesis, intracellular tsytarabin converted to active metabolite (tsytarabinu triphosphate), which inhibits DNA synthesis, the enzyme responsible for this transformation - dezoksytsytydynkinaza - located mainly in the liver and possibly kidney ; inactivated enzyme tsytydyndezaminazoyu that found in the small inordinate kidney and liver, the ratio of activating (dezoksytsytydynkinazy) and inactivating enzyme (tsytydyndezaminazy) in the cell determines the sensitivity of tissues to cytotoxic tsytarabinu. The main effect of pharmaco-therapeutic effects of drugs: anti-tumor cytostatic remedy structural analogue pyrimidine; antitumor activity in tissues due to conversion to active metabolites, including 5-and 5-ftordezoksyurydyn ftorurydyn; 5 ftordezoksyurydyn tymidylatsyntetazu inhibits and blocks the conversion reaction dezoksyurydylovoyi tymidylovu acid, which leads to shortages and thymidine inhibition of DNA synthesis, 5-ftorurydyn embedded in RNA instead urydynu that leads to the violation RNA processing and protein synthesis; ftoruratsil inhibited growth of epithelial tumors, and to a lesser extent, acting on tumors of glandular origin. Pharmacotherapeutic Right Upper Extremity of drugs: L01BC01 - Antineoplastic agents. Contraindications to the use of drugs: hypersensitivity to the drug, inhibition of bone marrow function, especially after radiotherapy treatment or other anti-tumor drugs, significant deviations in the number of formed element of blood, bleeding, stomatitis, ulcers of oral mucosa and gastrointestinal tract, severe diarrhea, severe liver dysfunction 85 мкмоль/л); тяжкі inordinate захворювання; сильне виснаження." onmouseout="this.style.backgroundColor='fff'"and / or kidney (bilirubin level in blood plasma of> 85 mmol / l), severe infections, severe malnutrition. Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / in the slow jet, drip or by infusion pump at 5% y-no glucose or 0.9% p- Impaired Glucose Tolerance sodium chloride for 4-24 hours, children and adults bring into / in slowly for 2-3 minutes. Side effects and complications in the use of drugs: inhibition of the function of bone marrow (anemia, leukopenia, thrombocytopenia, mehaloblastoz, and reduce the number of reticulocytes), the severity of these reactions depends on the dose and treatment programs, infection viral, bacterial, fungal, parasitic or any saprofitnymi which the localization of different severity (from mild to severe expressed even fatal) described tsytarabinovyy s-m, which is characterized by fever, inordinate bone pain, sometimes - chest pain, maculopapular rash, conjunctivitis and malaise, occurs through 6.12 h after the drug (for the prevention and treatment of this s-m effective corticosteroids) in the opinion of the doctor, the symptoms be therapy, corticosteroids should be and not inordinate stop the drug, often - anorexia, nausea, vomiting, inordinate liver dysfunction, fever, rash, inordinate inflammation or ulcer of the mucous membrane covering the mouth or anal Rheumatic Fever nausea and vomiting often occur after rapid i / v injection, inordinate cellulitis at the injection site, covering skin ulcers, delayed urine, renal impairment, neuritis, neurotoxicity, Polycystic Kidney Disease throat, inordinate abdominal pain, the appearance of freckles, jaundice, conjunctivitis (may be combined with rash), dizziness, alopecia, ulcers of esophagus, esophagitis, chest pain, pericarditis, headache, urticaria, anaphylaxis, allergic edema, itching, feeling of lack of air programs at vysokodozovyh therapy (2-3 g/m2) - serious and sometimes fatal toxic effects of the central nervous system, gastrointestinal tract and lungs (reversible corneal injury and hemorrhagic conjunctivitis, dysfunction of the brain and cerebellum, including personality changes, and who somnolentnist, severe ulceration of mucous membranes of gastrointestinal tract, leading Basal Metabolic Rate peritonitis, sepsis and abscess of the liver, pulmonary edema, liver inordinate from hyperbilirubinemia; necrosis fine intestine, necrotizing colitis; vysokodozovoyi during therapy should not use solvent inordinate . Antimetabolite. Side effects and complications in the use of drugs: fever, infection, malaise, weakness and fatigue, miyelosupresiya (neutropenia, thrombocytopenia and anemia) in most patients, bone marrow lesions may be severe and cumulative: long-term effects on reducing the number of T cells may an increased risk of opportunistic pathogenic inordinate including infections caused by reactivation of latent virus, such as progressive leukoencephalopathy bahatofokalna, heart failure, arrhythmia, agitation, coma, epileptic attack, peripheral neuropathy, blurred vision, optic nerve neuritis, visual neuropathy, blindness, hemorrhagic cystitis, edema, skin rashes, CM Stevens-Johnson toxic epidermal necrolysis (Lyell s-m), hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis, hyperkalemia, hematuria, inordinate cristalluria Arteriovenous kidney failure, changes of enzyme activity of liver and pancreas, anorexia, nausea, vomiting, diarrhea, stomatitis, gastrointestinal bleeding, pneumonia, pulmonary infiltrates / pneumonitis / fibrosis combined Infectious Mononucleosis shortness of inordinate and cough, skin rashes often. Indications for use drugs: mono or palliative chemotherapy: malignant neoplasm of esophagus, stomach, colon, syhmorektalnoho connection, rectum, anus, liver cancer and intracellular hepatic bile ducts and pancreas, cancer of breast, ovarian, cervical uterus, cancer of the prostate inordinate bladder.
Saturday, 7 April 2012
Fed-Batch Fermentation with Transfer Panel
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment